Cargando…

Predicting clinical outcomes using cancer progression associated signatures

Somatic mutation signatures are an informative facet of cancer aetiology, however they are rarely useful for predicting patient outcome. The aim of this study is to evaluate the utility of a panel of 142 mutation-signature–associated metrics (P142) for predicting cancer progression in patients from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mamrot, Jared, Hall, Nathan E., Lindley, Robyn A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057277/ https://www.ncbi.nlm.nih.gov/pubmed/33889305 http://dx.doi.org/10.18632/oncotarget.27934

Ejemplares similares

Molecular model linking Th2 polarized M2 tumour‐associated macrophages with deaminase‐mediated cancer progression mutation signatures
por: Mamrot, Jared, et al.
Publicado: (2019)

Association between targeted somatic mutation (TSM) signatures and HGS‐OvCa progression
por: Lindley, Robyn A., et al.
Publicado: (2016)

Construction of a novel cancer-associated fibroblast-related signature to predict clinical outcome and immune response in colon adenocarcinoma
por: Zheng, Lei, et al.
Publicado: (2023)

Prediction of clinical outcome and survival in soft-tissue sarcoma using a ten-lncRNA signature
por: He, Rong-quan, et al.
Publicado: (2017)

A novel ferroptosis-related gene signature for predicting outcomes in cervical cancer
por: Qi, Xingling, et al.
Publicado: (2021)

Immunometabolic Signatures Predict Risk of Progression to Active Tuberculosis and Disease Outcome
por: Duffy, Fergal J., et al.
Publicado: (2019)

Identification of colorectal cancer progression-associated intestinal microbiome and predictive signature construction
por: Liu, Jungang, et al.
Publicado: (2023)

Cyclin D1-mediated microRNA expression signature predicts breast cancer outcome
por: Wang, Guangxue, et al.
Publicado: (2018)

Clinical outcomes and potential therapies prediction of subgroups based on a ferroptosis-related long non-coding RNA signature for gastric cancer
por: Geng, Haigang, et al.
Publicado: (2022)

A new metabolic signature contributes to disease progression and predicts worse survival in melanoma
por: Wan, Mengdi, et al.
Publicado: (2020)

Immune gene signature delineates a subclass of thyroid cancer with unfavorable clinical outcomes
por: Zhi, Jingtai, et al.
Publicado: (2020)

Prediction of clinical prognosis in cutaneous melanoma using an immune-related gene pair signature
por: Yang, Yu, et al.
Publicado: (2021)

A Ferroptosis-Related Signature Robustly Predicts Clinical Outcomes and Associates With Immune Microenvironment for Thyroid Cancer
por: Ge, Mingqin, et al.
Publicado: (2021)

A three-lncRNA signature predicts clinical outcomes in low-grade glioma patients after radiotherapy
por: Lin, Wanzun, et al.
Publicado: (2020)

Immunobiological signatures and the emerging role of SPP1 in predicting tumor heterogeneity, malignancy, and clinical outcomes in stomach adenocarcinoma
por: Wu, Yanan, et al.
Publicado: (2023)

Development of an immunogenic cell death prognostic signature for predicting clinical outcome and immune infiltration characterization in stomach adenocarcinoma
por: Liu, Ye, et al.
Publicado: (2023)

The role of Angiogenesis and remodeling (AR) associated signature for predicting prognosis and clinical outcome of immunotherapy in pan-cancer
por: Sun, Xiaojiao, et al.
Publicado: (2022)

A novel methylation signature predicts inferior outcome of patients with PDAC
por: Gu, Minqi, et al.
Publicado: (2021)

A 4-miRNA signature predicts the therapeutic outcome of glioblastoma
por: Niyazi, Maximilian, et al.
Publicado: (2016)

The CINSARC signature predicts the clinical outcome in patients with Luminal B breast cancer
por: Goncalves, Anthony, et al.
Publicado: (2021)

Predicting the clinical outcome of melanoma using an immune-related gene pairs signature
por: Meng, Liangliang, et al.
Publicado: (2020)

Cytokine Response Signatures in Disease Progression and Development of Severe Clinical Outcomes for Leptospirosis
por: Reis, Eliana A. G., et al.
Publicado: (2013)

EMT-induced metabolite signature identifies poor clinical outcome
por: Bhowmik, Salil Kumar, et al.
Publicado: (2015)

Optimized outcome prediction in breast cancer by combining the 70-gene signature with clinical risk prediction algorithms
por: Drukker, C. A., et al.
Publicado: (2014)

Stathmin and phospho-stathmin protein signature is associated with survival outcomes of breast cancer patients
por: Kuang, Xia-Ying, et al.
Publicado: (2015)

Development and validation of a cancer-associated fibroblast-derived lncRNA signature for predicting clinical outcomes in colorectal cancer
por: Pan, Hongda, et al.
Publicado: (2022)

Prediction of bladder cancer outcome by identifying and validating a mutation-derived genomic instability-associated long noncoding RNA (lncRNA) signature
por: Wu, Hao, et al.
Publicado: (2021)

Development of an immune-related signature for predicting survival outcome and immunotherapy response in osteosarcoma
por: Wang, Qinghua, et al.
Publicado: (2021)

TRAP1 protein signature predicts outcome in human metastatic colorectal carcinoma
por: Maddalena, Francesca, et al.
Publicado: (2017)

Serum-based microRNA signature predicts relapse and therapeutic outcome of adjuvant chemotherapy in colorectal cancer patients
por: Ji, Dengbo, et al.
Publicado: (2018)

Assessment of clinical variables as predictive markers in the development and progression of colorectal cancer
por: Rasool, Mahmood, et al.
Publicado: (2021)

A core matrisome gene signature predicts cancer outcome
por: Yuzhalin, Arseniy E, et al.
Publicado: (2018)

Signaling protein signature predicts clinical outcome of non-small-cell lung cancer
por: Jin, Bao-Feng, et al.
Publicado: (2018)

Heat shock proteins create a signature to predict the clinical outcome in breast cancer
por: Klimczak, Marta, et al.
Publicado: (2019)

Predicting clinical outcomes of cancer patients with a p53 deficiency gene signature
por: Schaafsma, Evelien, et al.
Publicado: (2022)

Immune infiltration and a ferroptosis-associated gene signature for predicting the prognosis of patients with endometrial cancer
por: Weijiao, Yin, et al.
Publicado: (2021)

Gain-of-function miRNA signature by mutant p53 associates with poor cancer outcome
por: Zhang, Yao, et al.
Publicado: (2016)

Identification and validation of hypoxia-derived gene signatures to predict clinical outcomes and therapeutic responses in stage I lung adenocarcinoma patients
por: Shi, Run, et al.
Publicado: (2021)

Seven Genes Based Novel Signature Predicts Clinical Outcome and Platinum Sensitivity of High Grade IIIc Serous Ovarian Carcinoma
por: Liu, Gang, et al.
Publicado: (2018)

Identification of pyroptosis-related signature for cervical cancer predicting prognosis
por: Zhou, Cankun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5efi5onm7pa0s5n794329er5pi